Product Information
NORVIR 100 MG TABLET is a brand product labeled by AbbVie Inc., priced at $8.3489 per EA under NDC 00074234030. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Feb 10, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Ritonavir market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
AbbVie Inc.NDC
00074234030
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
RITONAVIRApproval Type
New Drug (NDA)
FDA Application
NDA022417FDA Approved
2/10/2010
TE Code
AB
On Market Since
8/16/2022
Pharmacological Classes
Price Statistics
The NADAC for NORVIR 100 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.3489 per EA |
|---|---|
| All-time high | $8.3505 (Jul 16, 2025) |
| All-time low | $8.3001 (Aug 20, 2025) |
| 52-week high | $8.3489 |
| 52-week low | $8.3281 |
| Median price | $8.3391 |
| Average price | $8.3390 |
| Largest weekly change | +0.5% (Sep 17, 2025) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 93% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AbbVie Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ritonavir market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cytochrome P450 3A Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NORVIR 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NORVIR 100 MG TABLET, manufactured by AbbVie Inc., is $8.3489 per EA (NDC 00074234030), effective Sep 30, 2026.
How has the price of NORVIR 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for NORVIR 100 MG TABLET has held within roughly two percent of its current level. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for NORVIR 100 MG TABLET?
Since Apr 17, 2024, the NADAC for NORVIR 100 MG TABLET has ranged from a low of $8.3001 (Aug 20, 2025) to a high of $8.3505 (Jul 16, 2025), with a median of $8.3391 per EA.
Are there cheaper alternatives to NORVIR 100 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RITONAVIR 100 MG TABLET, is $0.6066 per EA — about 93% below NORVIR 100 MG TABLET.
Who manufactures NORVIR 100 MG TABLET?
NORVIR 100 MG TABLET (NDC 00074234030) is labeled by AbbVie Inc., and CMS classifies it as a brand product.